The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Treatment for Respiratory Disease Market Research Report 2024
Synopsis
Respiratory diseases may be caused by infection, by smoking tobacco, or by breathing in secondhand tobacco smoke, radon, asbestos, or other forms of air pollution. Respiratory diseases include asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and lung cancer.
The global Drug Treatment for Respiratory Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Nebulization inhalation therapy is an important treatment method for respiratory system-related diseases. Compared with oral administration, intramuscular injection and intravenous administration, aerosol inhalation therapy has the advantages of rapid onset of action, good curative effect, fewer systemic adverse reactions, and does not require the patient's deliberate cooperation because the drug directly acts on the target organ. It has been adopted domestically. Widely used outside.
This report aims to provide a comprehensive presentation of the global market for Drug Treatment for Respiratory Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Treatment for Respiratory Disease.
The Drug Treatment for Respiratory Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Treatment for Respiratory Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Treatment for Respiratory Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
Segment by Type
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Lung Cancer
Other Diseases
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Treatment for Respiratory Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Respiratory diseases may be caused by infection, by smoking tobacco, or by breathing in secondhand tobacco smoke, radon, asbestos, or other forms of air pollution. Respiratory diseases include asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pneumonia, and lung cancer.
The global Drug Treatment for Respiratory Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Nebulization inhalation therapy is an important treatment method for respiratory system-related diseases. Compared with oral administration, intramuscular injection and intravenous administration, aerosol inhalation therapy has the advantages of rapid onset of action, good curative effect, fewer systemic adverse reactions, and does not require the patient's deliberate cooperation because the drug directly acts on the target organ. It has been adopted domestically. Widely used outside.
This report aims to provide a comprehensive presentation of the global market for Drug Treatment for Respiratory Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Treatment for Respiratory Disease.
The Drug Treatment for Respiratory Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Treatment for Respiratory Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Treatment for Respiratory Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
Segment by Type
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Lung Cancer
Other Diseases
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Treatment for Respiratory Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Asthma
1.2.3 Chronic Obstructive Pulmonary Disease (COPD)
1.2.4 Lung Cancer
1.2.5 Other Diseases
1.3 Market by Application
1.3.1 Global Drug Treatment for Respiratory Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Treatment for Respiratory Disease Market Perspective (2019-2030)
2.2 Global Drug Treatment for Respiratory Disease Growth Trends by Region
2.2.1 Global Drug Treatment for Respiratory Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Treatment for Respiratory Disease Historic Market Size by Region (2019-2024)
2.2.3 Drug Treatment for Respiratory Disease Forecasted Market Size by Region (2025-2030)
2.3 Drug Treatment for Respiratory Disease Market Dynamics
2.3.1 Drug Treatment for Respiratory Disease Industry Trends
2.3.2 Drug Treatment for Respiratory Disease Market Drivers
2.3.3 Drug Treatment for Respiratory Disease Market Challenges
2.3.4 Drug Treatment for Respiratory Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Treatment for Respiratory Disease Players by Revenue
3.1.1 Global Top Drug Treatment for Respiratory Disease Players by Revenue (2019-2024)
3.1.2 Global Drug Treatment for Respiratory Disease Revenue Market Share by Players (2019-2024)
3.2 Global Drug Treatment for Respiratory Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Treatment for Respiratory Disease Revenue
3.4 Global Drug Treatment for Respiratory Disease Market Concentration Ratio
3.4.1 Global Drug Treatment for Respiratory Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Treatment for Respiratory Disease Revenue in 2023
3.5 Global Key Players of Drug Treatment for Respiratory Disease Head office and Area Served
3.6 Global Key Players of Drug Treatment for Respiratory Disease, Product and Application
3.7 Global Key Players of Drug Treatment for Respiratory Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Treatment for Respiratory Disease Breakdown Data by Type
4.1 Global Drug Treatment for Respiratory Disease Historic Market Size by Type (2019-2024)
4.2 Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (2025-2030)
5 Drug Treatment for Respiratory Disease Breakdown Data by Application
5.1 Global Drug Treatment for Respiratory Disease Historic Market Size by Application (2019-2024)
5.2 Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Treatment for Respiratory Disease Market Size (2019-2030)
6.2 North America Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
6.4 North America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Treatment for Respiratory Disease Market Size (2019-2030)
7.2 Europe Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
7.4 Europe Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Treatment for Respiratory Disease Market Size (2019-2030)
8.2 Asia-Pacific Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Treatment for Respiratory Disease Market Size (2019-2030)
9.2 Latin America Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
9.4 Latin America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Treatment for Respiratory Disease Market Size (2019-2030)
10.2 Middle East & Africa Drug Treatment for Respiratory Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Drug Treatment for Respiratory Disease Introduction
11.1.4 GSK Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Drug Treatment for Respiratory Disease Introduction
11.2.4 AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Drug Treatment for Respiratory Disease Introduction
11.3.4 Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Drug Treatment for Respiratory Disease Introduction
11.4.4 Novartis Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Drug Treatment for Respiratory Disease Introduction
11.5.4 Mylan Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.5.5 Mylan Recent Development
11.6 Vertex Pharmaceuticals
11.6.1 Vertex Pharmaceuticals Company Details
11.6.2 Vertex Pharmaceuticals Business Overview
11.6.3 Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Introduction
11.6.4 Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.6.5 Vertex Pharmaceuticals Recent Development
11.7 F. Hoffman La Roche
11.7.1 F. Hoffman La Roche Company Details
11.7.2 F. Hoffman La Roche Business Overview
11.7.3 F. Hoffman La Roche Drug Treatment for Respiratory Disease Introduction
11.7.4 F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.7.5 F. Hoffman La Roche Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Drug Treatment for Respiratory Disease Introduction
11.8.4 Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Details
11.9.2 Cipla Business Overview
11.9.3 Cipla Drug Treatment for Respiratory Disease Introduction
11.9.4 Cipla Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.9.5 Cipla Recent Development
11.10 Fibrogen
11.10.1 Fibrogen Company Details
11.10.2 Fibrogen Business Overview
11.10.3 Fibrogen Drug Treatment for Respiratory Disease Introduction
11.10.4 Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.10.5 Fibrogen Recent Development
11.11 Liminal Biosciences
11.11.1 Liminal Biosciences Company Details
11.11.2 Liminal Biosciences Business Overview
11.11.3 Liminal Biosciences Drug Treatment for Respiratory Disease Introduction
11.11.4 Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.11.5 Liminal Biosciences Recent Development
11.12 PharmAkea Therapeutics
11.12.1 PharmAkea Therapeutics Company Details
11.12.2 PharmAkea Therapeutics Business Overview
11.12.3 PharmAkea Therapeutics Drug Treatment for Respiratory Disease Introduction
11.12.4 PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.12.5 PharmAkea Therapeutics Recent Development
11.13 IQVIA
11.13.1 IQVIA Company Details
11.13.2 IQVIA Business Overview
11.13.3 IQVIA Drug Treatment for Respiratory Disease Introduction
11.13.4 IQVIA Revenue in Drug Treatment for Respiratory Disease Business (2019-2024)
11.13.5 IQVIA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Treatment for Respiratory Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Asthma
Table 3. Key Players of Chronic Obstructive Pulmonary Disease (COPD)
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other Diseases
Table 6. Global Drug Treatment for Respiratory Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Drug Treatment for Respiratory Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Drug Treatment for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Drug Treatment for Respiratory Disease Market Share by Region (2019-2024)
Table 10. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Drug Treatment for Respiratory Disease Market Share by Region (2025-2030)
Table 12. Drug Treatment for Respiratory Disease Market Trends
Table 13. Drug Treatment for Respiratory Disease Market Drivers
Table 14. Drug Treatment for Respiratory Disease Market Challenges
Table 15. Drug Treatment for Respiratory Disease Market Restraints
Table 16. Global Drug Treatment for Respiratory Disease Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Drug Treatment for Respiratory Disease Market Share by Players (2019-2024)
Table 18. Global Top Drug Treatment for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Treatment for Respiratory Disease as of 2023)
Table 19. Ranking of Global Top Drug Treatment for Respiratory Disease Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Drug Treatment for Respiratory Disease Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Drug Treatment for Respiratory Disease, Headquarters and Area Served
Table 22. Global Key Players of Drug Treatment for Respiratory Disease, Product and Application
Table 23. Global Key Players of Drug Treatment for Respiratory Disease, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug Treatment for Respiratory Disease Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2019-2024)
Table 27. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Drug Treatment for Respiratory Disease Revenue Market Share by Type (2025-2030)
Table 29. Global Drug Treatment for Respiratory Disease Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2019-2024)
Table 31. Global Drug Treatment for Respiratory Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Drug Treatment for Respiratory Disease Revenue Market Share by Application (2025-2030)
Table 33. North America Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Drug Treatment for Respiratory Disease Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug Treatment for Respiratory Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Drug Treatment for Respiratory Disease Market Size by Country (2025-2030) & (US$ Million)
Table 48. GSK Company Details
Table 49. GSK Business Overview
Table 50. GSK Drug Treatment for Respiratory Disease Product
Table 51. GSK Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 52. GSK Recent Development
Table 53. AstraZeneca Company Details
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Drug Treatment for Respiratory Disease Product
Table 56. AstraZeneca Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Boehringer Ingelheim Company Details
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Drug Treatment for Respiratory Disease Product
Table 61. Boehringer Ingelheim Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 62. Boehringer Ingelheim Recent Development
Table 63. Novartis Company Details
Table 64. Novartis Business Overview
Table 65. Novartis Drug Treatment for Respiratory Disease Product
Table 66. Novartis Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Mylan Company Details
Table 69. Mylan Business Overview
Table 70. Mylan Drug Treatment for Respiratory Disease Product
Table 71. Mylan Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 72. Mylan Recent Development
Table 73. Vertex Pharmaceuticals Company Details
Table 74. Vertex Pharmaceuticals Business Overview
Table 75. Vertex Pharmaceuticals Drug Treatment for Respiratory Disease Product
Table 76. Vertex Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 77. Vertex Pharmaceuticals Recent Development
Table 78. F. Hoffman La Roche Company Details
Table 79. F. Hoffman La Roche Business Overview
Table 80. F. Hoffman La Roche Drug Treatment for Respiratory Disease Product
Table 81. F. Hoffman La Roche Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 82. F. Hoffman La Roche Recent Development
Table 83. Teva Pharmaceuticals Company Details
Table 84. Teva Pharmaceuticals Business Overview
Table 85. Teva Pharmaceuticals Drug Treatment for Respiratory Disease Product
Table 86. Teva Pharmaceuticals Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 87. Teva Pharmaceuticals Recent Development
Table 88. Cipla Company Details
Table 89. Cipla Business Overview
Table 90. Cipla Drug Treatment for Respiratory Disease Product
Table 91. Cipla Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 92. Cipla Recent Development
Table 93. Fibrogen Company Details
Table 94. Fibrogen Business Overview
Table 95. Fibrogen Drug Treatment for Respiratory Disease Product
Table 96. Fibrogen Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 97. Fibrogen Recent Development
Table 98. Liminal Biosciences Company Details
Table 99. Liminal Biosciences Business Overview
Table 100. Liminal Biosciences Drug Treatment for Respiratory Disease Product
Table 101. Liminal Biosciences Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 102. Liminal Biosciences Recent Development
Table 103. PharmAkea Therapeutics Company Details
Table 104. PharmAkea Therapeutics Business Overview
Table 105. PharmAkea Therapeutics Drug Treatment for Respiratory Disease Product
Table 106. PharmAkea Therapeutics Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 107. PharmAkea Therapeutics Recent Development
Table 108. IQVIA Company Details
Table 109. IQVIA Business Overview
Table 110. IQVIA Drug Treatment for Respiratory Disease Product
Table 111. IQVIA Revenue in Drug Treatment for Respiratory Disease Business (2019-2024) & (US$ Million)
Table 112. IQVIA Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Drug Treatment for Respiratory Disease Picture
Figure 2. Global Drug Treatment for Respiratory Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drug Treatment for Respiratory Disease Market Share by Type: 2023 VS 2030
Figure 4. Asthma Features
Figure 5. Chronic Obstructive Pulmonary Disease (COPD) Features
Figure 6. Lung Cancer Features
Figure 7. Other Diseases Features
Figure 8. Global Drug Treatment for Respiratory Disease Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Drug Treatment for Respiratory Disease Market Share by Application: 2023 VS 2030
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Drug Treatment for Respiratory Disease Report Years Considered
Figure 14. Global Drug Treatment for Respiratory Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Drug Treatment for Respiratory Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Drug Treatment for Respiratory Disease Market Share by Region: 2023 VS 2030
Figure 17. Global Drug Treatment for Respiratory Disease Market Share by Players in 2023
Figure 18. Global Top Drug Treatment for Respiratory Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Treatment for Respiratory Disease as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Drug Treatment for Respiratory Disease Revenue in 2023
Figure 20. North America Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)
Figure 22. United States Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)
Figure 26. Germany Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Drug Treatment for Respiratory Disease Market Share by Region (2019-2030)
Figure 34. China Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)
Figure 42. Mexico Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Drug Treatment for Respiratory Disease Market Share by Country (2019-2030)
Figure 46. Turkey Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. UAE Drug Treatment for Respiratory Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. GSK Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 53. Mylan Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 54. Vertex Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 55. F. Hoffman La Roche Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 57. Cipla Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 58. Fibrogen Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 59. Liminal Biosciences Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 60. PharmAkea Therapeutics Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 61. IQVIA Revenue Growth Rate in Drug Treatment for Respiratory Disease Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
